INTRODUCTION
============

Proteins that traverse the eukaryotic secretory pathway fold in the oxidizing environment of the endoplasmic reticulum (ER) ([@B14]). Because protein folding and maturation are error-prone steps, a quality control process is in place in the ER to evaluate the structural integrity of maturing proteins ([@B43]; [@B92]; [@B59]). Properly folded proteins are permitted to traffic to various locations within the cell to perform their activities, whereas misfolded proteins are targeted for retention and subsequent degradation. The triaging decision that evaluates proteins in the ER as native or aberrant is based on the exposure of general nonnative structural hallmarks such as exposed hydrophobic residues or free thiols ([@B27]; [@B3]). Because of these different fundamental properties, it is relatively straightforward to conceptualize how a quality control process could differentiate between native and aberrant substrates for a diverse array of proteins. The more difficult decision to envision is how the cellular quality control machinery discriminates between immature folding intermediates that transiently display nonnative characteristics and terminally misfolded structures. In other words, how does the quality control process distinguish an on-pathway foldable intermediate that should be provided further time to mature compared with an irreparable off-pathway misfolded product that should be targeted for turnover? Understanding how these fundamental quality control sorting decisions are made and implemented is important for understanding protein homeostasis and the basis for a large number of disease states that are caused by inefficient maturation, subsequent degradation, or toxic accumulation of secretory pathway cargo or an overzealous quality control process that inappropriately retains and degrades active client proteins ([@B43]; [@B8]; [@B40]).

Mammalian secretory pathway cargoes are commonly glycosylated, and the process of glycoprotein quality control uses glycans as protein maturation or quality control tags ([@B15]; [@B45]; [@B20]; [@B59]; [@B44]; [@B42]). The composition of a substrate\'s N-linked glycans dictates downstream carbohydrate-based interactions that support ER retention, exit, or degradation. Carbohydrates are generally added to the nascent chains cotranslationally as they enter the ER lumen ([@B1]). A preassembled Glc~3~Man~9~GlcNAc~2~ (Glc, glucose; Man, mannose; GlcNAc~2~, *N*-acetylglucosamine) glycan is transferred to the consensus site en bloc by the oligosaccharyltransferase complex. The glycan is then rapidly trimmed to the monoglucosylated form by the sequential actions of glucosidases I and II. The monoglucosylated glycoform is recognized by the carbohydrate-binding chaperone calnexin and its soluble paralogue calreticulin, which assist in the maturation of the nascent chain ([@B45]; [@B41]; [@B74]). Trimming of the last glucose releases the glycoproteins from these lectin chaperones or ablates their rebinding. Uridine diphosphate (UDP)-glucose:glycoprotein glucosyltransferase 1 (UGT1) is an ER-resident protein that helps in the maturation of glycoproteins by reglucosylating maturing proteins, therefore supporting additional rounds of lectin chaperone binding ([@B20]). Although UGT1 appears to be a central protein sensor in the ER, its role in quality control is not completely understood.

An ER reglucosylation activity was discovered by Parodi and colleagues, and in these early studies, they found that microsomal extracts glucosylated isolated thyroglobulin, a large and heavily glycosylated secretory protein ([@B88]). The reglucosylation activity from ER extracts preferentially modified denatured thyroglobulin compared with the native protein. These results were supported by subsequent studies using UGT purified from rat livers, *Schizosaccharomyces pombe*, and *Drosophila*, and smaller, more-defined substrates such as ribonuclease B, phytohemagglutinin, and soybean agglutinin ([@B83]; [@B90]; [@B33]; [@B72]). Although these studies were in agreement with the conclusion that UGT1 efficiently modified nonnative substrates, more recent studies have investigated the properties of the nonnative proteins that most effectively supported reglucosylation to characterize the specificity of UGT1. Isolated UGT1 was found to favor the modification of near-native folding intermediates or orphan subunits over native or extensively misfolded substrates ([@B89]; [@B18], [@B19]; [@B86]; [@B54]; [@B79]). The reglucosylation activity of UGT1 even serves to retain assembled major histocompatibility class I antigen presentation complex (MHC I) in the ER until it is loaded with a high-affinity peptide ([@B95]; Blum *et al.*, 2013b). These results suggested that UGT1 has the ability to monitor slight structural aberrations, which has led to the postulation that UGT1 can differentiate between on-pathway foldable substrates and off-pathway terminal misfolded secretory cargo, thereby directing the rebinding of the lectin chaperones toward on-pathway salvageable targets that might eventually fold and oligomerize properly.

*UGT1* is an essential gene for mouse viability, but an UGT1-deficient mouse embryonic fibroblast cell line has been used to explore the role of UGT1 in the ER ([@B66]; [@B82]; [@B75]; [@B95]). The absence of UGT1 has diverse consequences for glycosylated secretory cargo, including the following: 1) premature release from the lectin chaperones, resulting in a decrease in trafficking or secretion efficiency; 2) delay in the release from the lectin chaperones and ER exit; or 3) no effect on lectin chaperone binding and secretion. Determining whether UGT1 is providing a direct or indirect effect using these knockout cells is complicated by the fact that UGT1 modifies a wide range of substrates that may be influenced by its absence and that UGT1 is found in a protein complex ([@B55]; [@B64]; [@B75]).

Although the substrate specificity of UGT1 has been studied using purified components, its activity in mammalian cells has been poorly defined due to a number of experimental obstacles hindering the ability to monitor the reglucosylation process ([@B73], [@B75]). Here a cell-based reglucosylation assay was used to characterize the activity of UGT1 in its native environment. The hypothesis that UGT1 favors the reglucosylation of on-pathway over off-pathway targets was tested. In contrast to what has previously been proposed ([@B19]; [@B26]), UGT1 was found to reglucosylate off-pathway maturation substrates more efficiently and persistently than wild-type maturing secretory pathway clients. Trapping wild-type UGT1 substrates in the monoglucosylated state delayed their secretion, whereas trapping off-pathway substrates in the monoglucosylated state did not affect their rate of degradation. This suggested that terminally misfolded substrates were efficiently extracted from the lectin chaperone binding cycle and targeted for degradation through a dominant process that was unaffected by the presence of monoglucosylated side chains on the substrate.

RESULTS
=======

The reglucosylation of ER-associated degradation substrates
-----------------------------------------------------------

To explore the substrate specificity of UGT1 in live cells, the reglucosylation of model maturation and quality control substrates was analyzed using a cellular reglucosylation assay. MI8-5 Chinese hamster ovary cells are deficient in the dolichol-P glucose--dependent glycosyltransferase termed Alg6 ([@B77]). Truncated unglucosylated N-linked glycans lacking glucoses (Man~9~GlcNAc~2~) are transferred instead of the normal triglucosylated species (Glc~3~Man~9~GlcNAc~2~). Reglucosylation is the sole mechanism through which glycoproteins can reach the monoglucosylated state in these cells ([Figure 1A](#F1){ref-type="fig"}, bottom scheme). The reglucosylated or monoglucosylated proteins can be isolated based on their affinity for glutathione *S*-transferase (GST)--calreticulin ([@B73], [@B75]). Glucosidase inhibition traps reglucosylated glycans in their monoglucosylated state in MI8-5 Chinese hamster ovary cells since these Chinese hamster ovary--derived cells lack an endomannosidase activity ([@B52]), further facilitating the ability to monitor the reglucosylation reaction.

![Reglucosylation of ERAD and disease-associated mutants is efficient. (A) Schematic of glycan processing in MI8-5 and wild-type cells. Whereas wild-type cells allow the transfer of triglucosylated glycans onto the nascent chain, unglucosylated glycans are transferred in MI8-5 cells. Thus, monoglucosylated glycans can only be generated through reglucosylation by UGT1 in MI8-5 cells. G, glucose; GlsI, glucosidase I; GlsII, glucosidase II. (B) Right, MI8-5 Chinese hamster ovary cells were transiently transfected with an empty vector (mock) or with wild-type α-1-antitryspin (WT A1AT), α-1-antitrypsin *null* Hong Kong (NHK), and α-1-antitrypsin Z (A1ATZ). Cells were radiolabeled for 1 h and chased for the indicated times. DNJ, 0.5 mM, was added to the pulse and chase media. Monoglucosylated proteins were isolated by GST-calreticulin (CRT) pull down from 10% of the cell lysate each, and WT A1AT, NHK, and A1ATZ were isolated with A1AT antisera. Monoglucosylated WT A1AT, NHK, and A1ATZ were isolated by GST-CRT pull down, followed by immunoprecipitation with A1AT antisera from 80% of the cell lysate. All samples were resolved on 9% SDS--PAGE reducing gels. The numbers next to the bands indicate the number of glycans on A1AT. The asterisk indicates the previously identified endogenous UGT1 substrate prosaposin. Left, quantification of the percentage of reglucosylation of WT A1AT, NHK, and A1ATZ. The quantifications of the fully glycosylated A1AT (top band) from lanes 19--24 were divided by the quantifications from lanes 11--16, which were multiplied by eight to account for lower percentage of sample used. The error bars are representative of the SD of five independent experiments. (C) Right, MI8-5 Chinese hamster ovary cells were transiently transfected with FLAG tagged α-NAGAL, wild type, and E367K mutant and treated as in B. α-NAGAL was isolated with antisera recognizing the FLAG epitope from 10% of the cell lysate, and an equal fraction was followed by EndoH treatment where indicated. Monoglucosylated α-NAGAL was isolated by GST-CRT pull down, followed by immunoprecipitation with FLAG antisera from 70% of the cell lysate. All samples were resolved on a 9% SDS--PAGE reducing gel. Left, quantification of the percentage of reglucosylation of α-NAGAL was performed as in B. The error bars are representative of the SD of three independent experiments. (D) Right, MI8-5 Chinese hamster ovary cells were transiently transfected with HA-tagged TCRα and treated as in B. TCRα was isolated with antisera recognizing the HA epitope and total radiolabeled monoglucosylated proteins with GST-CRT from 10% of the cell lysate. Monoglucosylated TCRα was isolated by GST-CRT pull down, followed by immunoprecipitation with HA antisera from 80% of the cell lysate. All samples were resolved on a 12% SDS--PAGE reducing gel. Left, quantification of the percentage of reglucosylation of TCRα was performed as in B. The error bars are representative of the SD of three independent experiments. (E) Right, MI8-5 Chinese hamster ovary cells were transiently transfected with FLAG-tagged tyrosinase, wild type, and C89R mutant and treated as in B. Total and monoglucosylated tyrosinase were isolated as in C. Left, quantification of the percentage of reglucosylation of tyrosinase was performed as in B. Statistical analysis using single-factor analysis of variance test gave *p* of 0.04\<0.05 for WT A1AT compared with NHK and Z mutants at 0 h, *p* of 0.001 and 0.004\<0.01 for WT A1AT compared with NHK and Z mutant, respectively, at 1 h, and *p* of 0.03\<0.05 for WT α-NAGAL compared with the E367K at 1 h, indicating that the increase in reglucosylation of the mutants relative to WT at the indicated time points is statistically significant.](390fig1){#F1}

α-1-Antitrypsin (A1AT) was chosen as the initial substrate to evaluate for reglucosylation since it has a number of mutations with varying levels of structural perturbations and is associated with disease. A1AT is a soluble secretory glycoprotein synthesized in hepatocytes that belongs to the serine protease inhibitor or serpin family of proteins. Serpins are monomeric proteins comprised of three sheets and nine helices. Three different variants of A1AT were expressed in MI8-5 cells, including wild type and two mutant variants termed *null* Hong Kong (NHK) and A1ATZ. NHK is a frameshift and premature truncation mutation that is associated with gross misfolding, ER retention, and rapid subsequent turnover by ER-associated degradation (ERAD) ([@B81]; [@B62]). It was named *null* because it was found to be absent from serum. A common pathological variant of A1AT is A1ATZ, which is caused by a single site mutation (E342K) ([@B9]). A1ATZ contains structural perturbations that slow its folding and favor polymerization ([@B13]; [@B53]). Although ∼15% of A1ATZ is secreted, the remainder is ER retained and degraded by both ERAD and autophagy ([@B63]; [@B46]). The retention of polymerized A1ATZ in the ER of hepatocytes is associated with cirrhosis.

Cells transfected with A1AT were pulsed for 1 h with \[^35^S\]Met/Cys and analyzed either directly after the pulse or after a 1-h chase ([Figure 1B](#F1){ref-type="fig"}). The pulse and chase were performed in the presence of the glucosidase inhibitor *N*-butyl deoxynojirimycin (DNJ) to trap reglucosylated glycans. Cell lines defective in assembling the complete dolichol precursor, such as MI8-5, are commonly associated with the hypoglycosylation of nascent proteins since the oligosaccharyltransferase frequently transfers the incompletely assembled glycan inefficiently ([@B49]). The hypoglycosylation of A1AT was observed for all three forms after immunoprecipitation of the samples with anti-A1AT sera, resulting in the formation of a ladder of glycosylation states ranging from the faster-migrating unglycosylated protein to the slower-migrating, fully glycosylated protein containing all three glycans ([Figure 1B](#F1){ref-type="fig"}, lanes 11--16). To confirm that the multiple bands of A1AT were caused by hypoglycosylation, we treated samples with peptide N-glycosidase F (PNGase F) to remove any heterogeneity attributed to N-linked carbohydrates. All protein bands observed collapsed into a single band migrating with the same mobility as unglycosylated A1AT, demonstrating that the different protein bands resolved were due to different levels of glycosylation ([Figure 2A](#F2){ref-type="fig"}, lanes 1--6).

![Trapping WT A1AT and the endogenous substrate prosaposin (Psap) in the monoglucosylated state reduced their secretion efficiency and prolonged chaperone binding. (A) MI8-5 Chinese hamster ovary cells were transiently transfected with WT A1AT, radiolabeled for 30 min, and chased for the indicated times. DNJ, 0.5 mM, was added to the pulse and chase media where indicated. WT A1AT was isolated with A1AT antisera from 12% of the cell lysate or the media, and an equal fraction was treated with PNGase F. Monoglucosylated WT A1AT was isolated by GST-CRT pull down, followed by immunoprecipitation with A1AT antisera from 50% of the cell lysate or the media. All samples were resolved on a 9% SDS--PAGE reducing gel. (B) MI8-5 Chinese hamster ovary cells were radiolabeled for 30 min and chased for the indicated times. DNJ, 0.5 mM, was added to the pulse and chase media where indicated. Psap was isolated with Psap antisera from 30% of the lysate or the media. Monoglucosylated Psap was isolated by GST-CRT pull down, followed by immunoprecipitation with Psap antisera from 60% of the cell lysate. All samples were resolved on a 9% SDS--PAGE reducing gel. The asterisk indicates cleaved Psap products. (C) Quantification of the percentage of the fully glycosylated (top band) WT A1AT (top) and endogenous prosaposin (bottom) secreted into the media as a percentage of synthesis. The error bars are representative of the SD from three independent experiments. (D) MI8-5 Chinese hamster ovary cells were radiolabeled for 1 h and chased for the indicated times. Psap was isolated from 5% of the lysate with Psap antisera and calreticulin (CRT)- and calnexin (CNX)-bound species from 15% of the lysate with their respective antisera. For sequential immunoprecipitations, 65% of the lysate was sequentially immunoprecipitated as indicated. All samples were resolved via 7.5% reducing SDS--PAGE.](390fig2){#F2}

Reglucosylation or the presence of monoglucosylated glycans was probed by monitoring binding to GST-calreticulin, a bacterially expressed and purified lectin fusion protein ([@B73], [@B75]). A large number of proteins of a variety of sizes were found to be monoglucosylated ([Figure 1B](#F1){ref-type="fig"}, lanes 1--8). To characterize A1AT reglucosylation, the GST-calreticulin pull down was followed by the immunoprecipitation with anti-A1AT sera ([Figure 1B](#F1){ref-type="fig"}, lanes 17--24). Twenty percent of wild-type A1AT was reglucosylated immediately after the pulse, and this level diminished to 11% after a 1-h chase. Of interest, the level of reglucosylation doubled for A1AT mutants NHK and A1ATZ, and this level of ∼40% reglucosylation persisted after 1 h of chase. These values were calculated using A1AT possessing all three of its glycans; however similar reglucosylation efficiencies were obtained when all A1AT glycoforms were grouped. The fastest-migrating protein bands (unglycosylated A1AT) were not recognized by GST-calreticulin. Therefore, although all glycoforms of A1AT were reglucosylated, the terminally misfolded mutant forms were more efficiently reglucosylated than the wild-type protein, and the level of reglucosylation of the two mutant variants was similar even though they possessed different types of abnormalities.

To determine whether UGT1 efficiently modified other ERAD or disease-associated substrates, we studied the reglucosylation of several additional proteins. These included proteins with varying topologies, such as the soluble α-*N*-acetylgalactosaminidase (α-NAGAL), as well as two membrane proteins, T-cell receptor α-subunit (TCRα) and tyrosinase.

α−NAGAL is a lysosomal protein that possesses five N-linked glycans ([@B22]). There are a number of loss-of-function mutations in α-NAGAL that are associated with Schindler/Kanzaki disease ([@B23]). The reglucosylation of C-terminally tagged FLAG constructs of wild-type α−NAGAL and the missense E367K mutant was studied as described earlier. Samples were treated with endoglycosidase H (EndoH) to differentiate EndoH-sensitive ER glycoforms of α-NAGAL from protein that had trafficked through the Golgi and received complex sugars rendering them EndoH resistant. During the time frame studied, all forms of α-NAGAL appeared to be EndoH sensitive, consistent with their ER residency. The level of reglucosylation for wild-type protein (7%) was lower than that observed for the E367K mutant (10%) immediately after the pulse ([Figure 1C](#F1){ref-type="fig"}). This trend continued after the 1-h chase. The α-NAGAL E367K mutant was more efficiently modified than the wild-type protein.

TCRα is a membrane glycoprotein that forms a larger heterocomplex in T lymphocytes; however, when it is unable to assemble, it is rapidly degraded through the ERAD pathway ([@B12]; [@B50]; [@B16]). MI8-5 cells were transfected with a TCRα construct containing a C-terminal hemagglutinin (HA) tag and pulsed for 1 h in \[^35^S\]Met/Cys, followed by a chase for the indicated times in the presence of a glucosidase inhibitor. TCRα was found to be efficiently (23--25%) and persistently reglucosylated regardless of the duration of the chase period ([Figure 1D](#F1){ref-type="fig"}).

Tyrosinase is a type I membrane glycoprotein with seven N-glycans that is involved in melanin biosynthesis ([@B91]). A C89R missense mutation for tyrosinase is an ERAD substrate, and this loss-of-function mutation is associated with albinism ([@B39]). MI8-5 cells were transfected with C-terminal FLAG constructs of either human wild-type tyrosinase or a C89R mutant, and a pulse-chase procedure was performed as described. Both wild-type and the C89R mutant of tyrosinase were efficiently reglucosylated, with only a very slight increase in the level for reglucosylation observed for C89R over wild type immediately after 1 h of chase ([Figure 1E](#F1){ref-type="fig"}).

MI8-5 cells supported the efficient glycosylation and reglucosylation of a variety of glycoproteins. Three of four glycoproteins studied were efficiently glycosylated, whereas a fourth protein (A1AT) was found to be hypoglycosylated, indicating that hypoglycosylation of glycoproteins in the MI8-5 cells was protein dependent. All four proteins were efficiently reglucosylated. The level for reglucosylation for the two mutants of A1AT was double that observed for wild-type A1AT. Wild-type α-NAGAL and tyrosinase were efficiently reglucosylated, but the reglucosylation of their mutants was associated with only a modest increase in modification, and in the case if tyrosinase, it was seen only after a 1-h chase.

Trapping proteins in their monoglucosylated state delays their secretion
------------------------------------------------------------------------

Reglucosylation of proteins by UGT1 supports their rebinding to the lectin chaperones calnexin and calreticulin ([@B20]). To determine whether trapping glycoproteins in their monoglucosylated state would affect their secretion, we performed a pulse-chase experiment using MI8-5 cells transfected with wild-type A1AT in the absence and presence of DNJ. Cell lysates and the culture medium were collected and analyzed.

The ability of glucosidase inhibition to trap wild-type A1AT in a monoglucosylated state was verified, as the addition of DNJ greatly increased the level of reglucosylation observed with the lysate samples after sequential precipitation with GST-calreticulin and anti-A1AT sera ([Figure 2A](#F2){ref-type="fig"}, compare lanes 7--9 to lanes 25--27). Trapping A1AT in the monoglucosylated state was also associated with a significant decrease in secretion, as less than half the amount of A1AT was found in the culture medium after a 2-h chase when DNJ was present compared with in its absence ([Figure 2, A](#F2){ref-type="fig"}, compare lanes 10--12 to lanes 28--30, and [C](#F2){ref-type="fig"}). The secreted protein found in the medium was largely not glucosylated as probed by GST-calreticulin binding ([Figure 2A](#F2){ref-type="fig"}, lanes 16--18 and 34--36). These results demonstrated that the inhibition of deglucosylation of reglucosylated protein delayed the secretion of ectopically expressed wild-type A1AT.

Because quality control pathways can be saturated by protein overexpression, the effect of trapping a reglucosylated substrate on the secretion of an endogenous UGT1 substrate was analyzed. Previously we found that prosaposin was an obligate substrate for UGT1, as it was efficiently reglucosylated in MI8-5 cells, and its maturation was inefficient in *ugt1*^−*/*−^ mouse embryonic fibroblast cells ([@B75]). As previously observed, glucosidase inhibition trapped a significant fraction of the prosaposin in the monoglucosylated state ([Figure 2B](#F2){ref-type="fig"}, lanes 13--15). Furthermore, glucosidase inhibition and monoglucosylation trapping were associated with less than half the amount of prosaposin being secreted into the culture medium after 2 h of chase ([Figure 2B](#F2){ref-type="fig"}, lanes 9 and 18, and [C](#F2){ref-type="fig"}). The delay in secretion of prosaposin in the presence of DNJ appeared to be due to calreticulin and calnexin binding to prosaposin, as chaperone binding levels increased in the presence of the glucosidase inhibitor ([Figure 2D](#F2){ref-type="fig"}, compare lanes 3--6 and lanes 21--24). Taken together, these results demonstrated that trapping either ectopically expressed wild-type A1AT or endogenously expressed prosaposin in the monoglucosylated state significantly inhibited their secretion.

Trapping ERAD substrates in their monoglucosylated state does not delay their turnover
--------------------------------------------------------------------------------------

Next we determined whether trapping an efficiently reglucosylated ERAD substrate in the monoglucosylated state would influence its turnover. First, the reglucosylation and secretion of NHK was followed in MI8-5 cells in the absence and presence of DNJ by pulse-chase analysis. NHK was not secreted regardless of whether DNJ was excluded or included in the pulse and chase conditions, demonstrating the effectiveness of the quality control process in retaining and degrading this terminally misfolded protein and recapitulating the *null* phenotype ([Figure 3A](#F3){ref-type="fig"}, lanes 9--12 and 29--32). A fraction of NHK was also observed in the Triton X-100--insoluble material ([Figure 3A](#F3){ref-type="fig"}, lanes 13--16 and 33--36). This fraction was included in the quantification of the amount of NHK remaining before and after trapping in the monoglucosylated state. Glucosidase inhibition efficiently captured NHK in the monoglucosylated state as observed by sequential pull downs with GST-calreticulin and anti-A1AT sera ([Figure 3A](#F3){ref-type="fig"}, compare lanes 25--28 to lanes 5--8). Of interest, trapping NHK in the monoglucosylated glycoforms did not influence the half-life of NHK regardless of the conditions used ([Figure 3B](#F3){ref-type="fig"}). Monoglucosylated NHK was detected in the detergent insoluble fraction even after 6 h of chase, indicating that insoluble NHK was also reglucosylated ([Figure 3A](#F3){ref-type="fig"}, lanes 37--40). The increase in NHK levels observed after the addition of proteasome (MG132) or the mannosidase (kifunensine) inhibitors demonstrated that NHK continued to be degraded by ERAD in the absence or presence of glucosidase inhibition ([Figure 3, C and D](#F3){ref-type="fig"}).

![Trapping NHK in the monoglucosylated state did not change its degradation rate. (A) MI8-5 Chinese hamster ovary cells were transiently transfected with NHK, radiolabeled for 30 min, and chased for the indicated times. DNJ, 0.5 mM, was added to the pulse and chase media where indicated. NHK was isolated with A1AT antisera from 10% of the lysate, the medium, or the Triton X-100--insoluble fraction. Monoglucosylated NHK was isolated by GST-CRT pull down, followed by immunoprecipitation with A1AT antisera from 80% of the cell lysate or the Triton X-100--insoluble fraction. All samples were resolved on a 9% SDS--PAGE reducing gel. (B) Quantification of the percentage of NHK from the lysate and the Triton X-100--insoluble fraction as a percentage of synthesis. The first bar for each time point corresponds to control conditions, and the second corresponds to DNJ treatment. All bands were quantified because the fully glycosylated (NHK top band) was not always well resolved in the later time points or the insoluble fraction. The error bars are representative of the SD of three independent experiments. (C) Cells were treated as in A. MG132 (20 μM) or kifunensine (100 μM) was added 4 and 2 h, respectively, before the pulse and included in the pulse and the chase where indicated. All samples were resolved on a 9% reducing SDS--PAGE gel. (D) Quantification of the percentage of the sum of NHK from the cell lysate and the Triton X-100--insoluble fraction as a percentage of synthesis (4-h chase). The error bars are representative of the SD of three independent experiments.](390fig3){#F3}

To test the generality of this result, we investigated whether trapping another ERAD substrate, TCRα, in the monoglucosylated state would affect its disposal by ERAD. Persistent monoglucosylation of TCRα was observed in the presence of the glucosidase inhibitor as observed by pull down with GST-calreticulin followed by immunoprecipitation with anti-HA sera ([Figure 4A](#F4){ref-type="fig"}, compare lanes 13--16 to lanes 5--8). The half-life of TCRα was not significantly affected by the presence of the glucosidase inhibitor, as the half-life of TCRα was ∼1 h in the absence or presence of DNJ ([Figure 4B](#F4){ref-type="fig"}). TCRα was not detected in the Triton X-100--insoluble material (unpublished data), indicating that TCRα analyzed using the detergent-soluble fraction was representative of the total amount of the protein remaining. TCRα was degraded by ERAD, as MG132 inhibited its turnover; however, mannosidase inhibition stabilization was less efficient ([Figure 4, C and D](#F4){ref-type="fig"}). Taken together, these results demonstrated that degradation of the ERAD substrates NHK and TCRα was unaffected by being trapped in the monoglucosylated state.

![Trapping TCRα in the monoglucosylated state did not change its degradation rate. (A) MI8-5 Chinese hamster ovary cells were transiently transfected with TCRα, radiolabeled for 30 min, and chased for the indicated times. DNJ, 0.5 mM, was added to the pulse and chase media where indicated. TCRα was isolated with HA antisera from 40% of the lysate. Monoglucosylated TCRα was isolated by GST-CRT pull down, followed by immunoprecipitation with HA antisera from 50% of the cell lysate. All samples were resolved on a 9% SDS--PAGE reducing gel. (B) Quantification of the percentage of TCRα from the lysate as a percentage of synthesis. The error bars are representative of the SD of three independent experiments. (C) Cells were treated as in A. MG132 (20 μM) or kifunensine (100 μM) was added 4 and 2 h, respectively, before the pulse and included in the pulse and the chase where indicated. (D) Quantification of the percentage of TCRα from the cell lysate as a percentage of synthesis (2-h chase). The error bars are representative of the SD of four independent experiments for no treatment and three independent experiments for MG132 and kifunensine treatments.](390fig4){#F4}

The timing and persistence of reglucosylation
---------------------------------------------

The previous experimental strategy trapped reglucosylated substrates in their monoglucosylated state to query the influence on secretion or degradation. Because the persistent trap did not allow the determination of the timing for reglucosylation, a transient 15-min window of glucosidase inhibition was applied at various time points with respect to the radioactive pulse and the cold chase to trap reglucosylated substrates over a range of times. Reglucosylated substrates were isolated using GST-calreticulin, followed by the immunoprecipitation of the specific substrate.

After maturing properly in the ER, prosaposin has two separate fates: it can traffic to lysosomes, where it is processed by cathepsin D into four separate proteins that act as cofactors for different lipid hydrolases, or it can be secreted as a full-length protein, with only its signal sequence removed ([@B70]; [@B60]). To differentiate ER-resident prosaposin in cell lysates from lysosomal prosaposin, we treated prosaposin immunoprecipitated from cell lysates with EndoH. High-mannose glycoforms consistent with ER residence remain EndoH sensitive, whereas complex sugar glycoforms that have trafficked through the Golgi become EndoH resistant ([@B39]). Most of the prosaposin from cell lysates displayed an EndoH-sensitive profile throughout the experiment; however, after 15 min of chase, a fraction of prosaposin that increased slightly with time was found to be EndoH resistant ([Figure 5A](#F5){ref-type="fig"}, lanes 6 and 8).

![WT A1AT and prosaposin are transiently reglucosylated by UGT1, whereas reglucosylation of NHK is more persistent. (A) MI8-5 Chinese hamster ovary cells were radiolabeled for 30 min. Where indicated, 0.5 mM DNJ was added 15 min before the end of the pulse. DNJ was also added at the indicated times of the chase, followed by 15-min incubation. Prosaposin was isolated with prosaposin antisera, followed by treatment with EndoH where indicated. Monoglucosylated prosaposin was isolated by GST-CRT pull down, followed by immunoprecipitation with prosaposin antisera. All samples were resolved on a 9% SDS--PAGE reducing gel. (B) The quantification of the percentage of reglucosylation of prosaposin was performed as in [Figure 1](#F1){ref-type="fig"}, accounting for differences in amounts of sample used for each treatment as a percentage of EndoH-sensitive prosaposin, since this represents ER-localized protein compared with EndoH-resistant protein localized to the lysosome. The error bars are representative of the SD of three or more independent experiments. (C) MI8-5 Chinese hamster ovary cells where transfected with either WT or NHK A1AT and treated as in A. (D) The quantification of the percentage of reglucosylation of all bands was performed as in [Figure 1](#F1){ref-type="fig"} accounting for differences in amounts of sample used for each treatment. The error bars are representative of the SD of three or more independent experiments.](390fig5){#F5}

The reglucosylation of prosaposin was transient, as monoglucosylated protein was isolated by GST-calreticulin most effectively when DNJ was added during the 15-min pulse ([Figure 5, A](#F5){ref-type="fig"}, lanes 17 and 18, and [B](#F5){ref-type="fig"}). The amount of prosaposin trapped in the monoglucosylated state with the 15 min of DNJ treatment greatly decreased during the chase even though a significant fraction of prosaposin continued to be EndoH sensitive, signifying ER residence. A similar profile was observed for transiently expressed wild-type A1AT ([Figure 5, C and D](#F5){ref-type="fig"}). Monoglucosylated A1AT was generated only during the 15-min pulse period and did not accumulate after a chase period of 15 min or more.

In contrast, reglucosylation of the ERAD substrate NHK A1AT was more efficient during the pulse period, and reglucosylation persisted for the next hour ([Figure 5, C and D](#F5){ref-type="fig"}). After 105 min of chase, the reglucosylation level dropped to roughly one-third of its maximum. Whereas the Triton-insoluble fraction with wild-type A1AT remained empty throughout the chase period, the Triton-insoluble fraction for NHK increased in a time-dependent manner. The persistent reglucosylation of NHK appeared to contribute to its ER retention and the lack of appearance in the media to create the *null* phenotype. Overall these results indicated that for both prosaposin and wild-type A1AT, reglucosylation occurred early in the maturation process. Although protein remained in the ER during the extended chase period, it did not appear to be monoglucosylated. For the A1AT NHK mutant variant, reglucosylation occurred at a higher level and persisted, consistent with the conclusion that UGT1 reglucosylates off-pathway aberrant structures most efficiently.

Efficient reglucosylation of reduced protein
--------------------------------------------

Previous results suggested that UGT1 does not modify grossly misfolded proteins. This case was in part supported by the observation that in some cases, ER glucosyltransferases did not recognize reduced substrates ([@B31]; [@B78]; [@B73]). The timing of dithiothreitol (DTT) addition, its activation of the unfolded protein response (UPR), and the use of different species complicate the interpretation of these results ([@B87]). We determined whether DTT affected the reglucosylation of the obligate UGT1 substrate prosaposin using our cell-based reglucosylation assay. Cells were pulsed with \[^35^S\]Met/Cys for 30 min in the presence or absence of DTT and processed either immediately after the pulse or after an oxidative chase for 1 h. DNJ was added to trap reglucosylated substrates, and the samples were processed by immunoprecipitation and using GST-calreticulin pull downs.

Reduced prosaposin migrated more slowly than prosaposin that accumulated under oxidizing conditions, as free thiols were modified by the alkylating agent *N*-ethyl maleimide included in the lysis buffer ([Figure 6A](#F6){ref-type="fig"}, lanes 1--4). The amount of prosaposin was also significantly diminished by DTT treatment, likely due to the activation of UPR and translation attenuation. Maximal reglucosylation of prosaposin was observed immediately after the pulse when glucosidases were inhibited by DNJ ([Figure 6, A](#F6){ref-type="fig"}, lane 10, and [B](#F6){ref-type="fig"}), and this level dropped significantly after a 1-h oxidative chase ([Figure 6, A](#F6){ref-type="fig"}, lane 30, and [B](#F6){ref-type="fig"}). Optimal reglucosylation also occurred in the presence of DTT immediately after the pulse ([Figure 6, A](#F6){ref-type="fig"}, lane 12, and [B](#F6){ref-type="fig"}), but this level of reglucosylation remained elevated even after the chase. When oxidation was initiated posttranslationally, prosaposin was more efficiently reglucosylated compared with commencing oxidation during translation. This suggested that the posttranslation oxidation of prosaposin was not as efficient and created aberrant conformations that continued to be recognized by UGT1 even after 1 h of oxidation. Therefore optimal reglucosylation occurred immediately after the pulse regardless of whether DTT was present; however, DTT supported efficient and persistent reglucosylation, consistent with UGT1 preference for nonnative substrates.

![Reduced prosaposin is efficiently reglucosylated by UGT1. (A) Cells were radiolabeled for 30 min and chased for 1 h. Where indicated, 0.5 mM DNJ was added in the pulse and chase media. DTT, 5 mM, was added in the pulse medium where indicated and excluded from the chase medium. Prosaposin was isolated with prosaposin antisera. Monoglucosylated prosaposin was isolated by GST-CRT pull down, followed by immunoprecipitation with prosaposin antisera. All samples were resolved on a 9% SDS--PAGE reducing gel. (B) The quantification of the percentage of reglucosylation of prosaposin was performed as in [Figure 1](#F1){ref-type="fig"}, accounting for differences in amounts of sample used for each treatment. The error bars are representative of the SD of three or more independent experiments.](390fig6){#F6}

DISCUSSION
==========

A main question concerning the biological role of UGT1 as a central decision maker in the fate of glycoproteins in the ER is whether UGT1 is able to recognize productively folding immature and/or terminally misfolded proteins and how it affects the subsequent cellular fates of the proteins it modifies. Using a cell-based reglucosylation assay, we found that UGT1 generally glucosylated mutant off-pathway substrates more efficiently than wild-type substrates. Secretion of wild-type substrates was slowed and less efficient when they were trapped in the monoglucosylated state. Surprisingly, the turnover of off-pathway substrates was not affected by locking them in monoglucosylated states. These results suggested that UGT1 was capable of differentiating between native and nonnative proteins, but downstream factors appeared to play a dominant role in determining the fate of terminally misfolded proteins.

The initial studies using cell-free or purified protein assays showed that UGT1 favored the modification of nonnative compared with native conformations ([@B88]; [@B90]; [@B83]; [@B33]; [@B72]). More recent and detailed studies using biophysically characterized and engineered substrates further examined the specificity of UGT1 and found preferential reglucosylation of proteins that are partially structured or possess minor local folding defects ([@B78]; [@B89]; [@B18], [@B19]; [@B86]; [@B79]). In some of these reports, grossly misfolded structures were poorly modified. The glucosylation of biophysically characterized neoglycoproteins derived from C-terminal truncation fragments of chymotrypsin inhibitor 2 showed that UGT1 had a preference for fragments with molten globule--like conformations when compared with random coil or native conformations ([@B18], [@B19]). Consistent with the preference of ER glucosyltransferases for near-native targets, in some cases they did not efficiently modify reduced proteins ([@B32]; [@B78]; [@B73]). The reglucosylation of cruzipain in *Trypanosoma cruzi* was directed toward later oxidative intermediates that enabled binding by its lone lectin chaperone, calreticulin ([@B58]). An earlier study using MI8-5 cells found that late but not early oxidative intermediates of hemagglutinin were reglucosylated on membrane-proximal glycans, which supported persistent calnexin binding ([@B73]). From these results, it was concluded that UGT1 recognizes near-native substrates more efficiently than native or severely misfolded substrates. This suggested that UGT1 might possess the ability to redirect the binding of lectin chaperones to maturing substrates that are expected to be salvageable for eventual proper on-pathway folding and trafficking ([@B26]).

Our cellular results indicate a less discriminatory role for UGT1 in live cells, as UGT1 generally reglucosylated terminally misfolded mutant proteins more efficiently than immature wild-type proteins. UGT1 was capable of modifying both on-pathway and off-pathway targets. The Z-variant involves a missense mutation and self-associates to form ER-retained polymers ([@B63]). The less common NHK mutation consists of a frameshift at position Leu-318 that creates a premature termination codon at position 334, producing a more severe disruption to A1AT ([@B81]). NHK is ER retained and subsequently degraded by ERAD. Because A1AT comprises three sheets and nine helices, NHK is missing or has mutations in one or two of the strands from each of the three sheets. Although Z and NHK likely have very different levels of structural perturbations, they are both reglucosylated at approximately twice what is observed for wild-type A1AT, indicative of the ability of UGT1 to recognize terminally misfolded substrates. [@B34] found that the level of mutant A1AT in Triton-insoluble fractions was increased in MEF cells lacking UGT1, suggestive of a role for UGT1 in maintaining the solubility for glycoproteins. However, in our study, reglucosylated mutant A1AT was also found in the Triton-insoluble fractions, suggesting that reglucosylation did not ablate aggregation. These differences might be due to the hypoglycosylation or the constitutive activation of UPR found in MI8-5 cells ([@B73]).

The ERAD substrate TCRα was also efficiently reglucosylated, as were the disease-associated mutants for α-NAGAL and tyrosinase. However, the increase in the reglucosylation of the mutant for α-NAGAL compared with its wild-type counterpart was not as significant as was observed for A1AT, and no increase in reglucosylation was observed for the mutant of tyrosinase compared with wild type. The reglucosylation assay traps reglucosylated glycans after a single reglucosylation event. Therefore it cannot differentiate between the reglucosylation of folding intermediates that are transiently glucosylated and a terminally misfolded protein that might be persistently reglucosylated unless additional glycosylations sites on a protein are modified, supporting the more efficient affinity isolation with the GST-calreticulin pull down. Wild-type tyrosinase appears to be a slow and inefficient folder ([@B39]; [@B35]). α-NAGAL also appears to fold inefficiently in Chinese hamster ovary cells. This likely also helps to favor the efficient modification of their wild-type proteins, dampening the difference in reglucosylation between wild type and mutants. Maturation of these difficult folders may be further derailed in MI8-5 cells, since the transfer of Man~9~GlcNAc~2~ glycans bypasses the initial binding to calnexin and calreticulin initiated by glucosidase I and II trimming of the triglucosylated glycan. Lectin chaperone binding is solely directed by UGT1 reglucosylation in MI8-5 cells ([Figures 1A](#F1){ref-type="fig"} and [7A](#F7){ref-type="fig"}).

![Model for UGT1 reglucosylation of on- and off-pathway substrates. (A) In MI8-5 Chinese hamster ovary cells, unglucosylated glycans are transferred onto the protein. On-pathway substrates in the near-native conformations are transiently reglucosylated by UGT1 until folding is completed (top route). DNJ addition favors accumulation of these substrates in the UGT1 cycle, supporting prolonged chaperone binding and secretion delay (represented by the red arrows). In contrast, aberrant off-pathway substrates are more efficiently and persistently reglucosylated by UGT1 (as indicated by the more prominent arrows on the bottom route). The addition of the glucosidase inhibitor DNJ, despite trapping misfolded proteins in their monoglucosylated state, does not protect substrates from ERAD, as they are efficiently extracted for degradation by a dominant ERAD selection process (exhibited by the long red arrows). (B) In WT Chinese hamster ovary cells, monoglucosylated substrates generated by GlsI and GlsII trimming bind to the lectin chaperones. After trimming of the last glucose by GlsII, substrates are released from the lectin chaperones and continue to be recognized by UGT1 and proceed in the top or bottom routes as described in A.](390fig7){#F7}

Earlier studies using a Chinese hamster ovary--derived cell line that transfers Man~5~GlcNAc~2~ carbohydrates (MadIA214 cells) found that maturing HA was reglucosylated, as was as a mutant of ribophorin that is an ERAD substrate ([@B28], [@B29]). The fate of trapped monoglucosylated proteins was not followed, and the efficiency for the reglucosylation of the mutant of ribophorin was not compared with that for the native ER-resident protein. These studies showed the scope of proteins modified by the glucosyltransferase in live cells and that proteins possessing Man5 side chains are suitable substrates for modification. Given that mannosidase inhibitors stabilized mutant ribophorin expressed in MadIA214 cells that lacked B and C branch mannose residues, these results also suggest that mannose trimming of the A branch might be required for ERAD. Alternatively, these mannose derivatives might also inhibit the binding of ERAD factors to the downstream ERAD adapter SEL1L, as found for EDEM1, EDEM3, and OS-9 ([@B21]; [@B25]; [@B80]).

Proteomic and morphological studies indicated that UGT1 is largely situated in the smooth ER near ER-exit sites ([@B96]; [@B36]). This positioning is consistent with the observation that reglucosylation occurs posttranslationally after the nascent chain has been released from the ribosome-associated translocon, as ribosome-arrested nascent chains were unable to be reglucosylated ([@B73]). This provides an explanation for the observation that UGT1 displayed a preference for late oxidative intermediates or folding domains in MI8-5 Chinese hamster ovary cells and *T. cruzi* for *influenza* hemagglutinin and cruzipain, respectively ([@B58]; [@B73]). Therefore the localization and accessibility of the enzyme rather than an inherent specificity toward more mature substrates likely explain these findings.

Conflicting results have been obtained for the ability of UGT to modify reduced proteins. Several studies found that UGT did not modify reduced proteins, favoring the conclusion that UGT does not recognize grossly misfolded substrates ([@B31]; [@B78]; [@B89]; [@B73]). In some instances, reglucosylation was dependent on the alkylating agent used ([@B89]), whereas in other cases, UGT1 was found to modify reduced proteins ([@B94]; [@B86]). The absence of reglucosylation in microsomes or cells treated with DTT could be explained by either the timing being soon after synthesis, as reglucosylation appears to occur posttranslationally, or by problems with the protein bookkeeping in cells, as DTT induces the UPR that leads to protein translation attenuation. We found that DTT supported the efficient and persistent reglucosylation of endogenous prosaposin in cells, favoring the conclusion that UGT1 can modify severely misfolded nonnative substrates.

UGT1 can also recognize slight structural perturbations, as it efficiently modified the orphan subunit of the heteromeric T-cell receptor, TCRα. A recent study found that unassembled TCRα caused the release of its single transmembrane region into the ER lumen, where it was then targeted for ERAD ([@B30]). The ability of UGT1 to recognize slight alterations is also exploited for the regulation of cellular processes such as antigen presentation and calcium homeostasis by supporting the recruitment of lectin chaperones and their associated oxidoreductase, ERp57 ([@B17]; [@B61]; [@B51]; [@B10]; [@B56]). The reglucosylation of fully folded MHC class I heavy chain or SERCA2b modulates their function and localization. It is clear that UGT1 can recognize subtle aberrations in protein structure, but it also efficiently recognizes terminally misfolded substrates. UGT1 does not appear to have the ability to preferentially select on-pathway or repairable substrates for further lectin chaperone intervention but instead simply modified nonnative substrates.

The secretion of glucosylated trapped wild-type proteins was significantly delayed. A similar finding was previously observed for endogenous cruzipain in *T. cruzi*, which naturally transfers high-mannose glycans ([@B57]). In sharp contrast, the more efficient reglucosylation of ERAD substrates did not appear to influence their fate or the turnover of terminally misfolded proteins when glucosylated glycans were trapped on the substrate. This was suggestive of a dominant downstream ERAD sorting receptor playing an important role that was unaffected by the presence of glucosylated glycans or lectin chaperone binding. As mannoses were trimmed from the B and C branches in fission yeast *S. pombe*, glucosidase II activity toward the demannosylated substrate decreased, whereas reglucosylation was unaffected ([@B1]; [@B85]). This favored the accumulation of monoglucosylated side chains on slow-folding substrates, which would be ER retained, assisted, and protected by calnexin and calreticulin binding. However, cell-free mammalian assays have shown that mannose trimming diminishes the activity of UGT1 toward substrates ([@B83]), as well as the binding affinity of calreticulin and possibly calnexin ([@B84]). Mannose trimming also exposes α1,6-linked mannoses side chains on C chains, which act as degradation tags for recognition by the luminal ERAD receptors ([@B76]; [@B24]). Alternatively, A branch demannosylation would remove a glycoprotein from being a substrate for reglucosylation and subsequent lectin chaperone binding to possibly favor recognition by ERAD machinery ([@B69]). Therefore mannose trimming likely plays a key role in rapidly sorting the trapped glucosylated proteins for destruction. Understanding the precise mechanism by which mannose trimming contributes to the ERAD process is complicated by the dual role that N-linked glycans play in the secretory pathway, as they act as sorting and quality control tags, as well as docking tags, for ER machinery complex formation and targeting ([@B44]).

The recognition and modification of ERAD substrates by UGT1 appear to be more a consequence of the ability of UGT1 to recognize structural imperfections akin to molecular chaperones than of functional significance that directly affects the fate for defective proteins. Downstream ERAD receptors evidently efficiently sort defective cargo for destruction regardless of their glucosylation status. Our results favor the model that UGT1 modifies nonnative proteins regardless of whether they are on- or off-pathway ([Figure 7, A](#F7){ref-type="fig"} and [B](#F7){ref-type="fig"}). This query likely occurs after an initial period of maturation that is dictated by the localization of UGT1 and its access to the maturing nascent chain. Of importance, reglucosylation inhibits secretion of on-pathway substrates either by supporting persistent chaperone binding (bulk flow hypothesis) or inhibiting binding to anterograde targeting receptors (receptor-mediated selective transport hypothesis; [@B93]; [@B7]; [@B4]). The significance of the more efficient reglucosylation of off-pathway terminally misfolded substrates is uncertain, as they evidently display a signal that is efficiently recognized by a downstream ERAD receptor. Perhaps persistent lectin chaperone binding of the monoglucosylated substrate localizes the ERAD substrate to a location in the ER where ERAD receptors or mannosidases are concentrated, such as the proposed ER quality control compartment (ERQC), where calnexin, calreticulin, ER ManI, and EDEM1 have been localized but not UGT1 and ERp57 ([@B5]). Likely candidates to shepherd glycosylated proteins through this retrograde trafficking route include ER ManI/Man1B1, EDEM1-3, Os-9, and XTP3-B ([@B48], [@B47]; [@B65]; [@B68]; [@B37]; [@B44]; [@B71]; [@B2]; [@B67]). There is vigorous debate over the location, roles, and substrate selectivity for some of these factors.

Some diseases are caused by the ER retention of an otherwise active protein by an apparently overzealous quality control process ([@B38]) that is capable of recognizing slight imperfections found even associated with active proteins. If the quality control process could be relaxed for these substrates, proper trafficking could alleviate the loss-of-function disease. UGT1 is a prime candidate for modulation for diseases of this category, as the reglucosylation of wild-type on-pathway targets supported ER retention and delayed the secretion of potentially active substrates. The fact that the terminally misfolded substrates were still cleared efficiently and rapidly when proteins were trapped with monoglucosylated glycans suggests that the modulation of the activity of UGT1 might not disrupt the ERAD process and might provide an effective therapy for the treatment of some of these loss-of-function diseases. A recent study showed that recombinant ER ManI/Man1B1 was capable of trimming glucosylated glycans and favored the trimming of denatured proteins ([@B2]); however, there is debate on whether this exomannosidase is localized to the ER or Golgi and the necessity of its activity for ERAD ([@B5]; [@B71]; [@B67]). Further studies will be required to identify the mechanism by which reglucosylated ERAD substrates are efficiently recognized and targeted for degradation. Sorting out these concerns and the mechanism by which reglucosylated ERAD substrates are efficiently recognized and targeted for degradation will require further cellular experiments, as well as approaches using purified components.

MATERIALS AND METHODS
=====================

Reagents
--------

MI8-5 Chinese hamster ovary cells were a gift from S. Krag (Johns Hopkins University, Baltimore, MD; [@B77]). Plasmids for pGEX-3X GST-calreticulin, T-cell receptor α (TCRα) with HA tag at its C-terminus, human α1-antitrypsin, and α-NAGAL were from M. Michalak (University of Alberta, Edmonton, Canada), S. Fang (University of Maryland, Baltimore, MD), M. Ziak and J. Roth (University of Zurich, Zurich, Switzerland), and S. Garman (University of Massachusetts-Amherst, Amherst, MA), respectively. Polyclonal rabbit α1-antitrypsin (Dako, Glostrup, Denmark) and calreticulin antisera (Thermo Fisher Scientific, Waltham, MA), monoclonal mouse HA antibodies (Roche, Mannheim, Germany), and polyclonal goat antisera against murine prosaposin (G. Grabowski and Y. Sun, University of Cincinnati College of Medicine) were obtained as indicated. Cell culture material and Lipofectamine 2000 were purchased from Invitrogen (Carlsbad, CA) and polyethyleneimine from Polysciences (Warrington, PA). \[^35^S\]Met/Cys was acquired from PerkinElmer (Waltham, MA). Reduced glutathione Sepharose 4B and protein A Sepharose 4B were from GE Healthcare (Uppsala, Sweden) and protein G-plus agarose beads from Santa Cruz Biotechnology (Santa Cruz, CA). DNJ and kifunensine (KIF) were obtained from Toronto Research Chemicals (Toronto, Canada). PNGase F and EndoH were acquired from New England Biolabs (Ipswich, MA). All other reagents were purchased from Sigma-Aldrich (St. Louis, MO).

Transfection and metabolic labeling
-----------------------------------

MI8-5 Chinese hamster ovary cells were cultured in MEMα supplemented with 5 or 10% fetal bovine serum, 100 U/ml penicillin, and 100 mg/ml streptomycin at 34°C in 5% CO~2~. Nearly confluent cells were transfected with the indicated plasmid using Lipofectamine 2000 or polyethyleneimine according to manufacturer\'s instructions.

Cells were starved for 30 min or 1 h in Cys/Met-free medium with 0.5 mM DNJ where indicated and then pulse labeled with 60 μCi of \[^35^S\]Cys/Met in 3.5-cm plates for 30 min or 1 h as indicated. When analyzing degradation of TCRα or NHK, no prior amino acid starvation was performed. Instead, cells were preincubated with 0.5 mM DNJ for 30 min before pulse labeling. Immediately after the pulse, cells were washed with phosphate buffer solution (PBS; 137 mM NaCl, 2.7 mM KCl, 4.3 mM Na~2~HPO~4~, and 1.4 mM KH~2~PO~4~) and chased with regular growth medium for the indicated times. DNJ was present throughout the chase where indicated except for [Figure 5](#F5){ref-type="fig"}, where DNJ was added at the indicated times relative to the start of chase. Radiolabeled cells were washed twice with PBS on ice, followed by lysis with MNT buffer (20 mM 2-(*N*-morpholino) ethanesulfonic acid, 100 mM NaCl, 0.5% Triton X-100, 30 mM Tris-HCl, pH 7.5) containing 50 μM calpain inhibitor I, 1 μM pepstatin, 10 μg/ml aprotinin, 10 μg/ml leupeptin, 0.4 mM phenylmethylsulfonyl fluoride, and 20 mM *N*-ethyl maleimide. Media and the Triton X-100--insoluble pellet were collected where indicated. Cells were incubated as designated with 20 μM MG132 or 100 μM KIF for 4 or 2 h before the pulse, respectively.

Immunoprecipitations and SDS--PAGE
----------------------------------

The postnuclear fraction was precleared with 10% zysorbin for 1 h at 4°C and then incubated with antibody and protein A--Sepharose beads and rotated end over end for 14 h at 4°C, except with the prosaposin antibody, for which protein G--agarose was used. The Triton X-100--insoluble pellet was solubilized in 1% SDS in 100 mM Tris-HCl, pH 8, by high-speed vortexing at 22°C for 5 min, followed by heating for 10 min at 100°C and then sonication. The SDS was quenched by dilution with excess MNT buffer. The media and Triton X-100--insoluble fractions were also precleared with 10% zysorbin, and immunoprecipitations were conducted as described for the postnuclear supernatant. Immunopellets were washed with 100 mM Tris, pH 8.6, 300 mM NaCl, 0.1% SDS, and 0.05% Triton X-100. Proteins were eluted from beads with reducing sample buffer, and then SDS--PAGE was performed. Radiolabeled samples were visualized by phosphorimaging (FLA-500; Fujifilm, Tokyo, Japan) and quantified using MultiGauge software or ImageQuant (Fujifilm).

GST-calreticulin pull down
--------------------------

Recombinant GST-calreticulin was expressed in *Escherichia coli* and purified as previously described ([@B6]; [@B73]). A fraction of the cell lysate was incubated with 8 μg of purified GST-calreticulin prebound to reduced glutathione beads at 4°C and rotated end over end for 14 h. Samples were washed with 100 mM Tris, pH 8.6, 300 mM NaCl, 0.1% SDS, and 0.05% Triton X-100 and eluted with reducing sample buffer. If followed by immunoprecipitation, samples were eluted with 1% SDS in 10 mM Tris, pH 7.5, and 150 mM NaCl at 100°C and quenched with excess MNT buffer, followed by incubation with the corresponding antisera and Sepharose beads overnight and washing as described.

Coimmunoprecipitation studies with calnexin and calreticulin
------------------------------------------------------------

Cells were grown in 10-cm plates, lysed with 2% 3-\[(3-cholamidopropyl)dimethylammonio\]-1-propanesulfonate (CHAPS) in 50 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid and 200 mM NaCl, pH 7.5 (HBS), and incubated with the respective antibody for 3 h. Immunopellets were washed with 0.5% CHAPS in HBS and eluted from beads with reducing sample buffer. When followed by a second immunoprecipitation, samples were eluted with 1% SDS in 10 mM Tris, pH 7.5, and 150 mM NaCl at 100°C and quenched with excess 2% CHAPS in HBS, followed by incubation with the corresponding antisera and Sepharose beads overnight and washing with 0.5% CHAPS in HBS.

Calculation of percentages of reglucosylation
---------------------------------------------

The percentage of reglucosylation was calculated by dividing the number obtained from quantifying the bands in the lanes with the GST-calreticulin pull down followed by immunoprecipitation, by the number obtained from quantifying the bands in the lanes with the corresponding immunoprecipitation directed against the given substrate. Because different percentages of lysate were used to perform the GST-calreticulin pull down followed by immunoprecipitation and the immunoprecipitation alone, this number was accounted for in the division. The fully glycosylated bands were used for the quantification when they were well resolved. Otherwise, all bands were quantified.
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A1AT

:   α-1-antitrypsin

α-NAGAL

:   α-*N*-acetylgalactosaminidase

DNJ

:   *N*-butyl deoxynojirimycin

ER

:   endoplasmic reticulum

ERAD

:   endoplasmic reticulum--associated degradation

Glc

:   glucose

GlcNAc

:   *N*-acetylglucosamine

Man

:   mannose

NHK

:   *null* Hong Kong

TCRα

:   T-cell receptor α subunit

UGT1

:   uridine diphosphate (UDP)-glucose:glycoprotein glucosyltransferase 1.
